During the past decade, Cancer Centers of the Carolinas - Spartanburg conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 23 clinical trials were completed, i.e. on average, 2300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Centers of the Carolinas - Spartanburg" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 14 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Centers of the Carolinas - Spartanburg" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Centers of the Carolinas - Spartanburg" are "Breast Cancer" (11 trials), "Colorectal Cancer" (5 trials), "Lung Cancer" (5 trials), "Leukemia" (4 trials) and "Neurotoxicity" (4 trials). Many other conditions were trialed in "Cancer Centers of the Carolinas - Spartanburg" in a lesser frequency.

Most popular intervention types in "Cancer Centers of the Carolinas - Spartanburg" are "Drug" (27 trials), "Other" (17 trials), "Biological" (11 trials), "Radiation" (6 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (10 trials), "cyclophosphamide" (4 trials), "laboratory biomarker analysis" (4 trials), "bevacizumab" (3 trials) and "cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Centers of the Carolinas - Spartanburg" are 31 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Centers of the Carolinas - Spartanburg". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Cancer Centers of the Carolinas - Spartanburg, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Centers of the Carolinas - Spartanburg, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".